Body density and skinfold thickness at four sites were measured in 140 normal boys, 168 normal girls, and 6 boys and 7 girls with cystic fibrosis, all aged 8-14 y. Prediction equations for the normal boys and girls for the estimation of body-fat content from skinfold measurements were derived from linear regression of body density vs the log of the sum of the skinfold thickness. The relationship between body density and the log of the sum of the skinfold measurements differed from normal for the boys and girls with cystic fibrosis because of their high body density even though their large residual volume was corrected for. However the sum of skinfold measurements in the children with cystic fibrosis did not differ from normal. Thus body fat percent of these children with cystic fibrosis was underestimated when calculated from body density and invalid when calculated from skinfold thickness.

The present study investigated the behavioral effects of intracerebroventricular microinfusion of agmatine. Rats with low dose (10 microg), but not high dose (100 microg), of agmatine spent significantly less time in the enclosed arm and more time in the open arm in the elevated plus maze. In the water maze task, the high dose group displayed a transient impairment in searching for a hidden platform, whereas the low dose group had reduced latency in the first probe test. In the object recognition task, all groups could detect the novel object, but the low dose group spent significantly more time exploring displaced objects. Furthermore, the low dose group made significantly fewer errors in the working, but not the reference, memory version of the radial arm maze task. These results suggest that the behavioral effects of agmatine are task- and dose-dependent, and agmatine may be an anxiolytic and memory modulator.